Data as of Jan 23
| -0.59 / -3.55%|
The 6 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 45.50, with a high estimate of 59.74 and a low estimate of 13.12. The median estimate represents a +183.46% increase from the last price of 16.05.
The current consensus among 7 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.